Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI

European Radiology

Volumn 18, Issue 5, 2008, Pages 931-938

  Veltman, J ^a   Mann, R ^a   Kok, T ^b   Obdeijn, I M ^c   Hoogerbrugge, N ^a   Blickman, J G ^a   Boetes, C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

BRCA1; BRCA2; Breast; Mammography; MRI

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORPHOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MALE; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; BREAST TUMOR; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; IMAGE PROCESSING; LABORATORY DIAGNOSIS; MUTATION; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRAST MEDIA; FALSE NEGATIVE REACTIONS; FEMALE; GADOLINIUM DTPA; GENES, BRCA1; GENES, BRCA2; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MUTATION; RETROSPECTIVE STUDIES;

EID: 52049090336     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-0851-y     Document Type: Article

References (32)

1. M Krainer S Silva-Arrieta MG FitzGerald A Shimada C Ishioka R Kanamaru DJ MacDonald H Unsal DM Finkelstein A Bowcock KJ Isselbacher DA Haber 1997 Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer N Engl J Med 336 1416 1421 9145678 10.1056/NEJM199705153362003 1:CAS:528:DyaK2sXjsFaksLc%3D
2. D Ford DF Easton DT Bishop SA Narod DE Goldgar 1994 Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium Lancet 343 692 695 7907678 10.1016/S0140-6736(94)91578-4 1:STN:280:ByuC1c%2FmtFM%3D
3. H Meijers-Heijboer B van Geel WL van Putten SC Henzen-Logmans C Seynaeve MB Menke-Pluymers CC Bartels LC Verhoog AM van den Ouweland MF Niermeijer CT Brekelmans JG Klijn 2001 Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 345 159 164 11463009 10.1056/NEJM200107193450301 1:CAS:528:DC%2BD3MXlslSlt7g%3D
4. ND Kauff JM Satagopan ME Robson L Scheuer M Hensley CA Hudis NA Ellis J Boyd PI Borgen RR Barakat L Norton M Castiel K Nafa K Offit 2002 Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 1609 1615 12023992 10.1056/NEJMoa020119
5. J Cuzick T Powles U Veronesi J Forbes R Edwards S Ashley P Boyle 2003 Overview of the main outcomes in breast-cancer prevention trials Lancet 361 296 300 12559863 10.1016/S0140-6736(03)12342-2 1:STN:280:DC%2BD3s%2FltVCmsA%3D%3D
6. CK Kuhl S Schrading CC Leutner N Morakkabati-Spitz E Wardelmann R Fimmers W Kuhn HH Schild 2005 Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer J Clin Oncol 23 8469 8476 16293877 10.1200/JCO.2004.00.4960
7. M Kriege CT Brekelmans H Peterse IM Obdeijn C Boetes HM Zonderland SH Muller T Kok RA Manoliu AP Besnard MM Tilanus-Linthorst C Seynaeve CC Bartels S Meijer JC Oosterwijk N Hoogerbrugge RA Tollenaar HJ de Koning EJ Rutgers JG Klijn 2006 Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer Breast Cancer Res Treat 102 357 363 17051427 10.1007/s10549-006-9341-6
8. CK Kuhl RK Schmutzler CC Leutner A Kempe E Wardelmann A Hocke M Maringa U Pfeifer D Krebs HH Schild 2000 Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results Radiology 215 267 279 10751498 1:STN:280:DC%2BD3c3hslajsA%3D%3D
9. M Kriege CT Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn RA Manoliu T Kok H Peterse MM Tilanus-Linthorst SH Muller S Meijer JC Oosterwijk LV Beex RA Tollenaar HJ de Koning EJ Rutgers JG Klijn 2004 Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427 437 15282350 10.1056/NEJMoa031759 1:CAS:528:DC%2BD2cXmtFalu7o%3D
10. GM Newstead PB Baute HK Toth 1992 Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis Radiology 184 623 627 1324506 1:STN:280:By2A2snhslE%3D
11. AM Knutzen JJ Gisvold 1993 Likelihood of malignant disease for various categories of mammographically detected, nonpalpable breast lesions Mayo Clin Proc 68 454 460 8479209 1:STN:280:ByyB2c%2FoslM%3D
12. M Tilanus-Linthorst L Verhoog IM Obdeijn K Bartels M Menke-Pluymers A Eggermont J Klijn H Meijers-Heijboer T van der Kwast C Brekelmans 2002 A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography Int J Cancer 102 91 95 12353239 10.1002/ijc.10666 1:CAS:528:DC%2BD38XnvFCru7Y%3D
13. R Kaas R Kroger JH Hendriks AP Besnard W Koops FA Pameijer W Prevoo CE Loo SH Muller 2004 The significance of circumscribed malignant mammographic masses in the surveillance of BRCA 1/2 gene mutation carriers Eur Radiol 14 1647 1653 15083333 10.1007/s00330-004-2307-3 1:STN:280:DC%2BD2cvhtFentg%3D%3D
14. R Kaas R Kroger JL Peterse AA Hart SH Muller 2006 The correlation of mammographic-and histologic patterns of breast cancers in BRCA1 gene mutation carriers, compared to age-matched sporadic controls Eur Radiol 16 2842 2848 16924440 10.1007/s00330-006-0385-0 1:STN:280:DC%2BD28nosFOmsg%3D%3D
15. MO Leach CR Boggis AK Dixon DF Easton RA Eeles DG Evans FJ Gilbert I Griebsch RJ Hoff P Kessar SR Lakhani SM Moss A Nerurkar AR Padhani LJ Pointon D Thompson RM Warren 2005 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 1769 1778 15910949 10.1016/S0140-6736(05)66646-9 1:STN:280:DC%2BD2M3mvFCqtg%3D%3D
16. F Sardanelli F Podo G D'Agnolo A Verdecchia M Santaquilani R Musumeci G Trecate S Manoukian S Morassut C De Giacomi M Federico L Cortesi S Corcione S Cirillo V Marra A Cilotti C Di Maggio A Fausto L Preda C Zuiani A Contegiacomo A Orlacchio M Calabrese L Bonomo E Di Cesare M Tonutti P Panizza A Del Maschio 2007 Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results Radiology 242 698 715 17244718 10.1148/radiol.2423051965
17. F Sardanelli F Podo 2007 Breast MR imaging in women at high-risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17 873 887 17008989 10.1007/s00330-006-0389-9
18. U Wedegärtner U Bick K Wörtler E Rummeny G Bongartz 2001 Differentiation between benign and malignant findings on MR-mammography: usefulness of morphological criteria Eur Radiol 11 1645 1650 11511885 10.1007/s003300100885
19. CK Kuhl P Mielcareck S Klaschik C Leutner E Wardelmann J Gieseke HH Schild 1999 Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211 101 110 10189459 1:STN:280:DyaK1M3gsFCmtQ%3D%3D
20. American College of Radiology (2003) ACR BI-RADS: magnetic resonance imaging. In: ACR Breast Imaging Reporting and Data System. American College of Radiology, Reston
21. EA Sickles 1994 Nonpalpable, circumscribed, noncalcified solid breast masses: likelihood of malignancy based on lesion size and age of patient Radiology 192 439 442 8029411 1:STN:280:ByuA3c3itlY%3D
22. F Sardanelli A Iozzelli A Fausto 2003 MR imaging of the breast: indications, established technique, and new directions Eur Radiol 13 3 N28 N36 15015878 10.1007/s00330-003-0004-2
23. LJ Hamilton AJ Evans AR Wilson N Scott EJ Cornford SE Pinder HN Khan RD Macmillan 2004 Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma Clin Radiol 59 895 902 15451348 10.1016/j.crad.2004.03.013 1:STN:280:DC%2BD2cvot1Cmsw%3D%3D
24. C Zuiani GE Francescutti V Londero I Zunnui M Bazzocchi 2002 Ductal carcinoma in situ: is there a role for MRI? J Exp Clin Cancer Res 21 89 95 12585661 1:STN:280:DC%2BD3s%2FnsVGmtQ%3D%3D
25. CK Kuhl S Schrading HB Bieling E Wardelmann CC Leutner R Koenig W Kuhn HH Schild 2007 MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study Lancet 370 485 492 17693177 10.1016/S0140-6736(07)61232-X
26. SG Orel MD Schnall VA LiVolsi RH Troupin 1994 Suspicious breast lesions: MR imaging with radiologic-pathologic correlation Radiology 190 485 493 8284404 1:STN:280:ByuC3M3it1w%3D
27. MD Schnall J Blume DA Bluemke GA DeAngelis N DeBruhl S Harms SH Heywang-Kobrunner N Hylton CK Kuhl ED Pisano P Causer SJ Schnitt D Thickman CB Stelling PT Weatherall C Lehman CA Gatsonis 2006 Diagnostic architectural and dynamic features at breast MR imaging: multicenter study Radiology 238 42 53 16373758 10.1148/radiol.2381042117
28. RE Jimenez T Wallis DW Visscher 2001 Centrally necrotizing carcinomas of the breast: a distinct histologic subtype with aggressive clinical behavior Am J Surg Pathol 25 331 337 11224603 10.1097/00000478-200103000-00007 1:STN:280:DC%2BD3M7lvFeqsw%3D%3D
29. IK Komenaka BA Ditkoff KA Joseph D Russo P Gorroochurn M Ward E Horowitz MB El Tamer FR Schnabel 2004 The development of interval breast malignancies in patients with BRCA mutations Cancer 100 2079 2083 15139048 10.1002/cncr.20221 1:CAS:528:DC%2BD2cXksF2rsr0%3D
30. TM Kolb J Lichy JH Newhouse 2002 Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations Radiology 225 165 175 12355001 10.1148/radiol.2251011667
31. MT Mandelson N Oestreicher PL Porter D White CA Finder SH Taplin E White 2000 Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers J Natl Cancer Inst 92 1081 1087 10880551 10.1093/jnci/92.13.1081 1:STN:280:DC%2BD3cvivFyrtA%3D%3D
32. SK Plevritis AW Kurian BM Sigal BL Daniel DM Ikeda FE Stockdale AM Garber 2006 Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging JAMA 295 2374 2384 16720823 10.1001/jama.295.20.2374 1:CAS:528:DC%2BD28Xlt1WksL8%3D